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Abstract
Background: Since the identification of human immunodeficiency virus (HIV) infection, there have been significant
advances in its diagnosis and treatment, but there have been few contributions to the area of care quality. In 2010,
the Spanish AIDS Study Group (GeSIDA) published the document “Health quality indicators of GeSIDA for the care
of people infected with HIV/AIDS” in which standards are proposed for the purpose of improving and standardizing
the assistance provided to people infected with HIV. The purpose of this study was to evaluate the degree of
compliance with these indicators and to analyse whether adherence to the standards improves patient perception
of care quality in terms of their satisfaction with the health care they have received.
Methods: Compliance with GeSIDA indicators was analysed within a cohort of people living with HIV (PLHIV) in a
hospital in the Madrid region. To evaluate patient perception, the External Consultation User Satisfaction
Questionnaire (SUCE) was used, which is a tool that was previously validated in the Spanish population.
Results: A total of 334 patients were included. The level of adherence to the indicators was 74.46%. The score on
the SUCE questionnaire was 9.04 out of 10 (CI 95%: 8.90–9.19). Of the 47 indicators assessed, only 4 were related to
satisfaction with health care.
Conclusions: The levels of compliance with the indicators and patient satisfaction with health care were high.
Adherence to quality indicators showed little relation to patient-reported satisfaction.
Keywords: HIV, Acquired immunodeficiency syndrome, Quality indicators, Health care: patient satisfaction
Background
The desire to improve the quality of health care has led
to the development of assessment tools [1]. Donabe-
dian’s study [2] established the basis of the quality sys-
tems applied to health care and defined quality as “an
adaptation of the attention to the particular needs of
each case”, highlighting that the majority of health care
evaluations are limited to a recounting of the actions
undertaken, without taking into consideration their ef-
fects on health or the extent to which they meet the
needs of patients. In recent years, demand has grown for
health care that, in addition to being effective and
evidence-based, is perceived as satisfactory and beneficial
by the patient [3]. This perspective is especially import-
ant in patients with chronic diseases, such as infection
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with the human immunodeficiency virus (HIV), since
clinical and physiological measurements provide valuable
information for the physician but are often poorly corre-
lated with functional capacity and patient welfare [4]. In
the case of patients with HIV infection, the Spanish
AIDS Study Group (GeSIDA) published a document in
2010 that includes 66 indicators of care quality. Cur-
rently, patients with HIV infection have a longer life ex-
pectancy than they did historically and accumulate more
comorbidities, which means that health professionals
need to address issues beyond virological suppression
[5]. User satisfaction is one of the most relevant charac-
teristics that can be used to measure the quality of a ser-
vice and serves as the basis for the formulation of
appropriate health policies [6, 7].
Information reported by patients allows the implemen-
tation of actions to improve health care [8]. Some very
important elements of health care, such as the percep-
tion of the results from the patient’s perspective, are
poorly represented in the current health care indicators
[9]. In this context, it seems especially relevant to moni-
tor whether there is a relationship between the quality of
care achieved through compliance with the established
quality standards and the quality of care as perceived by
the patient.
The aim of this study was to evaluate the compliance
with the quality indicators established by the GeSIDA in
a cohort of people living with HIV (PLHIV) and to ana-
lyse the influence of those indicators on patient satisfac-
tion. Although some articles have been published on the
indicators of the quality of care in the HIV-positive
population in different contexts and their relationships
with different factors [10, 11], the impact of those indi-
cators on patient satisfaction has not been analysed.
Methods
Study design
This was a cross-sectional observational study of an
HIV-positive Spanish population.
Patients
In the analysis of compliance with the quality indicators,
all PLHIV over 18 years of age who started or continued
follow-up during the study period between September
2011 and November 2017 were included.
For the analysis of patient-reported satisfaction, pa-
tients who were not participating in active follow-up at
the time of the survey (due to death, transfer to another
centre or loss to follow-up), those who were not able to
respond (due to illiteracy, language barriers or poor
baseline situation), and those who declined to participate
were excluded.
The work was carried out in accordance with the
Helsinki declaration of 1974 (updated in 2000) and
current personal data protection regulations. It was ap-
proved by the Research Commission of the study centre
and by the Ethics Committee of the hospital. All patients
included in the satisfaction analysis signed the patient
information sheet and provided informed consent.
Quality indicators
The indicators of the quality of care for HIV-positive pa-
tients proposed by GeSIDA were used. There were 66
indicators published in 2010 [12], which were subse-
quently validated, demonstrating their reproducibility
and feasibility [13]. The indicators that all HIV units
should monitor to determine their status and identify
necessary improvement measures are considered rele-
vant. The indicators that must meet the established
standard so that the unit can be accredited are called
basic [12]. All the basic and relevant indicators were
analysed except for three: indicators 9-Relevant contents
of the initial assessment and 33-Periodic consultation re-
port could not be evaluated because the necessary data
were not available; neither indicator is considered rele-
vant. Indicator 52-Specific treatment of chronic hepatitis
C virus (HCV) was not analysed because during the
study period, the treatment of chronic hepatitis C was
based on direct-acting antiviral drugs and not on inter-
feron and ribavirin, as stated in the definition of the
indicator.
The analysis of compliance with the indicators was
carried out by the research team following the defini-
tions established by the GeSIDA experts. The informa-
tion necessary for the evaluation was obtained from the
electronic medical records and was collected in a specif-
ically designed database.
Study variables
To achieve the main goal of the study, patient satisfac-
tion was analysed by means of the survey “External Con-
sultation User Satisfaction Questionnaire” (SUCE), a
self-reported previously validated in the Spanish popula-
tion [14]. It consists of 12 items with a response scale
from 1, the worst rating, to 10, the best rating. It allows
the independent evaluation of the clinical quality by ana-
lysing aspects related to care by health personnel and
the administrative quality by analysing organizational
and structural aspects. By means of ROC curves, 6.3 was
established as a cut-off point to discriminate between
satisfied and unsatisfied patients [15].
The questionnaires were offered in English and Span-
ish at the end of the consultation, and the patients an-
swered them in a separate space, depositing them at the
end in an container located in the administrative area of
the centre.
Other relevant variables, such as age, sex, educational
level, country of origin, date of diagnosis of HIV
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infection, transmission mechanism, CD4+ cell count and
HIV viral load (VL), were analysed.
Statistical analysis
All analyses were performed with the statistical program
STATA 14 College Station, TX.
A descriptive analysis of the basic characteristics of all
the patients was performed; frequency distributions were
used for categorical variables, and means (standard devi-
ations) or medians (interquartile ranges) were used for
continuous variables, based on the normality of their
distributions. These characteristics were compared be-
tween all patients and those participating in the survey
with the chi-square test and Student’s t-test to assess the
representativeness of the sample.
Forty-seven indicators of the quality of care were eval-
uated with their 95% parametric confidence intervals
(CIs). An indicator was met when the 95% CI of the
compliance percentage contained the value defined as
the standard.
Linear regression models were used to estimate the
differences in means and 95% CIs with regard to the ef-
fect of compliance with the indicators on patient satis-
faction. For the regression analyses, the indicators
calculated at the individual level were included for the
patients who participated in the interviews.
To study which quality indicators were independently
associated with satisfaction, multivariable regression
models were constructed, in which independent vari-
ables were included in addition to the indicators age,
sex, transmission mechanism, country of origin, CD4+
cell count and VL at the time the questionnaire was
completed. Those variables with p < 0.05 were retained
in the model.
Results
A total of 334 patients with HIV infection were treated
in the outpatient clinic between September 2011 and
November 2017. Table 1 shows the descriptive analysis
of the patients. A total of 64.1% of the patients were
men. Forty-four were foreigners, and sub-Saharan Africa
was the most frequent place of origin (24.4%). Fifty per-
cent of the patients had been diagnosed before 2007
(IQR; 1996; 2013), and the most frequent infection risk
category was heterosexual (43.2%), followed by paren-
teral drug addict (PDA) (28.4%) and men who have sex
with men (MSM) (25.4%). On the first visit to the centre,
the median age was 42 years (IQR: 35; 49), the median
CD4+ lymphocyte count was 457 cells/mm3 (CI: 219;
Table 1 Characteristics of patients treated in the HIV program stratified by survey participation
Lost to follow-up, transferred,
dead





Number 93 77 164 334
Sex 0.664
Male 61 (65.6%) 46 (59.7%) 107 (65.2%) 214 (64.1%)
Female 32 (34.4%) 31 (40.3%) 57 (34.8%) 120 (35.9%)
Transmission 0.005
PDA 35 (37.6%) 18 (23.4%) 42 (25.t6%) 95 (28.4%)
Unknown 1 (1.1%) 5 (6.5%) 2 (1.2%) 8 (2.4%)
MSM 15 (16.1%) 14 (18.2%) 56 (34.1%) 85 (25.4%)
Heterosexual 42 (45.2%) 40 (51.9%) 62 (37.8%) 144 (43.2%)
Blood transfusion 0 (0.0%) 0 (0.0%) 1 (0.6%) 1 (0.3%)
Vertical 0 (0.0%) 0 (0.0%) 1 (0.6%) 1 (0.3%)
Country of origin 0.024
Spain 56 (60.2%) 36 (46.8%) 107 (65.2%) 199 (59.6%)
Other 37 (39.8%) 41 (53.2%) 57 (34.8%) 135 (40.4%)
Age at first visit, years 44.2 (37.2;49.3) 41.6 (31.9;48.8) 42.1 (34.1;47.4) 42.3 (34.6;48.5) 0.645
Viral load at first visit
Undetectable (< 50 copies/ml) 34 (36.6%) 39 (50.6%) 62 (37.8%) 135 (40.4%) 0.143
CD4+ cell count at first visit (cells/
mm3)
413.0 (179.0;639.0) 491.0 (237.0;747.0) 474.0 (215.5;698.0) 457.0 (219.0;
685.0)
0.227
Years of follow-up 1.0 (0.2;1.8) 4.3 (2.9;5.1) 3.6 (2.0;4.8) 2.9 (1.0;4.6) < 0.001
PDA Parenteral drug addiction
MSM Men who have sex with men
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685), and 40.4% had undetectable plasma VLs. The me-
dian follow-up time in the centre was 3 years (IQR: 1; 5).
To calculate the quality indicators, 334 PLHIV treated
in the outpatient clinic during the study period were in-
cluded. At the time of the survey, 93 patients were not
being followed up (lost to follow-up, transferred or died),
and 43 patients were excluded due to illiteracy, language
barriers, organic or psychiatric pathology that made it
impossible for them to complete the questionnaire or re-
fusal to participate. Of the 198 surveys administered,
172 were collected (87% response rate). In the satisfac-
tion analysis, 164 patients were included because 8 sur-
veys were not valid (Fig. 1).
There were differences between patients included
and excluded in the survey analysis. The percentage
of participation in the surveys was higher in patients
with longer follow-up times (p < 0.001), MSM (p =
0.005) and patients of Spanish nationality (p = 0.038)
(Table 1).
Quality indicators and user satisfaction
Compliance with the quality indicators was high: of the
47 indicators evaluated, 35 met the established standard
(74.46%). Table 2 shows the results of compliance with
each of the indicators. The SUCE scale score was 9.04
(95% CI: 8.90; 9.19) (Fig. 2). Based on the proposed cut-
off value of 6.3 [15], 98.16% of the patients were satis-
fied. The Clinical Quality Factor Score (9.48, 95% CI:
9.37;9 .60) was higher than the Administrative Quality
Score (8.56, 95% CI: 8.35; 8.76). Table 3 shows the uni-
variate analysis of quality indicators related to satisfac-
tion (SUCE). Those related to greater satisfaction were
16-Periodicity of visits [difference in means 95% CI: 0.62
(0.13;1.11)], 21-Vaccination against hepatitis A [differ-
ence in means 95% CI: 1.14 (0.16;2.12)] and 23-
Fig. 1 General outline of the study: patients included between 2011 and 2017
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Table 2 Quality indicators for all patients evaluated
N Indicator Patients evaluated by the
indicator








(N) (N) (%) (CI 95%) (%)
1 Specialized doctor care 100 100% Yes
2 Availability of diagnostic resources 100 Yes (all) Yes
3 External pharmacy for dispensing drugs No Yes No
4 Conditions of privacy and structural confidentiality 100 100% Yes
6 Delay in referral to specialized care 47 42 89.4 76.9 96.5 100% No
7 Late diagnosis of HIV in specialized care 106 28 26.4 18.3 35.9 < 25% Yes
8 HIV diagnosis with previous negative serology 106 64 60.4 50.4 69.7 80% No
10 Complementary tests in the initial assessment 334 322 96.4 93.8 98.1 95% Yes
11 HIV plasma viral load 334 334 100 98.9 100 100% Yes
12 Determination of lymphocyte subpopulations (CD4) 334 334 100 98.9 100 100% Yes
13 Health education at initial assessment 332 187 56.3 50.8 61.7 95% No
15 Indication of treatment with < 350 CD4 and
without prior ART
117 3 2.6 0.5 7.3 < 10% Yes
16 Periodicity of visits (regular follow-up) 218 193 88.5 83.5 92.4 85% Yes
17 Basic renal study in HIV+ patients 212 209 98.6 95.9 99.7 100% Yes
20 LTI detection 189 110 58.2 50.8 65.3 90% No
21 Vaccination against hepatitis A 58 54 93.1 83.3 98.1 85% Yes
22 Vaccination against hepatitis B 88 81 92.0 84.3 96.7 85% Yes
23 Vaccination against pneumococcal infection 213 193 90.6 85.9 94.2 85% Yes
24 Prophylaxis against Pneumocystis jirovecii and
Toxoplasma
42 41 97.6 87.4 99.9 100% Yes
25 Treatment and prevention of smoking 93 67 72.0 61.8 80.9 95% No
26 Alcohol intake assessment 218 8 3.7 1.6 7.1 95% No
29 Syphilis screening 149 68 45.6 37.5 54.0 70% No
30 LTI treatment 25 23 92.0 74.0 99.0 95% Yes
31 Loss to follow-up 255 14 5.5 3.0 9.0 ≤ 5% Yes
32 Recovery of failed appointments 84.9 85% Yes
35 Adaptation of initial ART to the guidelines 119 119 100 96.9 100 95% Yes
36 Initiation of ART in patients with symptomatic B/C
events
33 32 97.0 84.2 99.9 90% Yes
37 First visit after the establishment of ART 117 108 92.3 85.9 96.4 90% Yes
38 Undetectable viral load (< 50 copies/ml) at week 48 106 102 96.2 90.6 99.0 80% Yes
39 Treatment with Abacavir (ABC) without previous
HLA-B 5701
77 0 0 0 4.7 0% Yes
40 Treatment changes during the first year 98 20 20.4 12.9 29.7 < 30% Yes
41 Record of adherence to treatment 312 266 85.3 80.8 89.0 95% No
42 Study of resistance in case of virologic failure 45 41 91.1 78.8 97.5 90% Yes
44 Average expenditure per patient in first treatment 13 8710.8* ** Yes
45 ART in pregnant women with HIV 17 17 100 80.5 100 100% Yes
47 Vertical transmission incidence 17 0 0 0 19.5 < 1% Yes
49 Evaluation by CHILD or MELD for chronic liver
disease
12 6 50.0 21.1 78.9 100% No
50 Evaluation of hepatitis C virus coinfection 7 7 100 59.0 100 90% Yes
54 HBsAg patients receiving effective treatment 12 12 100 73.5 100 90% Yes
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Vaccination against pneumococcal infection [mean dif-
ference 95% CI: 0.74 (0.10;1.38).
In contrast, those who met the 26-Evaluation of
alcohol intake had a lower level of satisfaction [95%
difference in means 95% CI: − 1.20 (− 1.97; − 0.44)].
Foreign patients reported greater satisfaction than
Spaniards [95% CI difference: 0.42 (0.12;0.71)]
(Table 4).
Table 5 shows the multivariable analysis of
satisfaction-related factors (SUCE). The final satisfaction
model included the indicator 16-Periodicity of visits
(regular follow-up) and country of origin.
Discussion
The baseline characteristics of the 334 patients treated
at the centre were significantly different from those of
other Spanish cohorts [17, 18], with a higher percentage
of foreigners (40.42%), mainly from sub-Saharan Africa.
This may account for the fact that the most common
risk category was HTSX and not MSM, as in other pub-
lished series. Although the male sex predominated, there
were more women (36%) than usual in this type of study
[18].
Of the 198 surveys administered, 172 were collected,
with a response rate of 87%, which is much higher than
Table 2 Quality indicators for all patients evaluated (Continued)
N Indicator Patients evaluated by the
indicator








(N) (N) (%) (CI 95%) (%)
55 Ultrasound control in cirrhotic patients 8 4 50.0 15.7 84.3 90% No
56 Cardiovascular risk assessment 212 120 56.6 49.6 63.4 90% No
58 Patients with discharge report after hospitalization 80 80 100 95.5 100 100% Yes
59 Reports of discharge of deceased patients in the
hospital
12 12 100 73.5 100 100% Yes
60 Follow-up in outpatient clinic after hospital
discharge
74 74 100 95.1 100 100% Yes
62 Overall mortality rate in patients in follow-up 334 15 11.7 8.7 24.9 ≤ 25*** Yes
63 Mortality rate due to AIDS-related causes 334 3 3.2 1.0 9.8 Not established
64 Continuing education 100 75% Yes
* Cost in euros of initiating treatment in this population
** Median rates published in the corresponding year by GeSIDA (7506.5 (6556–9072)) [16]
*** Death rate per 1000 people/year
Fig. 2 Results of the satisfaction questionnaire (SUCE) in the interviewed patients
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that published in other works based on self-reported
questionnaires [14, 19–21].
A low response rate may result in a response bias if
the responding patients have significant differences from
non-responders [22, 23]. Some authors have proposed
that a response rate of at least 80% is acceptable [23, 24],
while a response rate of 60% would not be adequate in
terms of the representativeness of the sample [23].
Among the patients who participated in the survey,
Spaniards accounted for a higher proportion, which is
reasonable because the questionnaires were delivered in
Spanish and English, and not all foreign patients speak
those languages. The authors believe that by providing a
separate space in which to complete the surveys and an-
other in which to deliver them, both of which were out-
side of the consultation room, the participation of the
patients was not biased.
Quality indicators
Although the level of compliance with the quality indica-
tors was high, there are areas for improvement. With re-
gard to some indicators, for which the subjective feeling
of compliance is high, the result for the indicator was
lower than the recommended standard, probably
Table 3 Univariate analysis of quality indicators related to satisfaction (SUCE)
N Healthcare quality indicator SUCE
Mean difference (CI 95%)
6 Delay in referral to specialized care −0.26 (−1.33;0.81)
7 Late diagnosis of HIV in specialized care −0.23 (− 0.81;0.35)
8 HIV diagnosis with previous negative serology −0.10 (− 0.65;0.44)
10 Complementary tests in the initial assessment 0.01 (−1.07;1.10)
11 HIV plasma viral load –
12 Determination of lymphocyte subpopulations (CD4) –
13 Health education at initial assessment 0.24 (−0.06;0.54)
15 Indication of treatment with < 350 CD4 and without prior ART –
16 Periodicity of visits (regular follow-up) 0.62 (0.13;1.11)*
17 Basic renal study in HIV+ patients −0.57 (− 2.49;1.35)
20 LTI detection 0.09 (−0.27;0.44)
21 Vaccination against hepatitis A 1.14 (0.16;2.12)*
22 Vaccination against hepatitis B 0.49 (−0.41;1.40)
23 Vaccination against pneumococcal infection 0.74 (0.10;1.38)*
24 Prophylaxis against Pneumocystis jirovecii and Toxoplasma −0.14 (−3.03;2.76)
25 Treatment and prevention of smoking 0.11 (−0.52;0.75)
26 Alcohol intake assessment −1.20 (− 1.97; −0.44)*
29 Syphilis screening 0.03 (−0.35;0.41)
30 LTI treatment −0.60 (−2.18;0.98)
35 Adaptation of initial ART guidelines to the guidelines –
36 Initiation of ART in patients with symptomatic B/C events –
37 First visit after the establishment of ART −0.69 (−1.61;0.23)
38 Undetectable viral load (< 50 copies/ml) at week 48 −0.62 (−2.76;1.52)
39 Treatment with Abacavir (ABC) without previous HLA-B 5701 –
40 Treatment changes during the first year −0.08 (− 0.87;0.71)
41 Record of adherence to treatment 0.33 (− 0.14;0.79)
42 Study of resistance in case of virologic failure −0.48 (−1.85;0.90)
45 ART in pregnant women with HIV –
47 Vertical transmission incidence –
49 Evaluation by CHILD or MELD for chronic liver disease 1.67 (−1.34;4.67)
50 Evaluation of the hepatitis C virus coinfection –
54 HBsAg patients receiving effective treatment –
55 Ultrasound control in cirrhotic patients 1.25 (−3.23;5.73)
56 Cardiovascular risk assessment −0.01 (− 0.34;0.31)
* p-value < 0.05
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because there is not always a written record in the clin-
ical history of the actions performed, for example, indi-
cators 8-Proof of previous HIV serology, 13-Health
education in the initial assessment, 25-Treatment and
prevention of smoking and 41-Registration of adherence
to treatment.
There is another group of indicators related to the co-
morbidities of patients with which the level of compli-
ance was suboptimal: 29-Syphilis screening, 49-
Evaluation by CHILD or MELD for chronic liver disease,
55-Ultrasound control in cirrhotic patients and 56-As-
sessment of cardiovascular risk. Due to these results, the
performance protocols have been modified, and re-
minders have been placed in the clinical history to im-
prove compliance.
In the case of indicator 20-Detection of latent tubercu-
lous infection (LTI), which evaluates the performance of
LTI screening in the initial assessment, the disagreement
between the number of Mantoux tuberculin skin tests
requested and performed stands out; the increasingly
widespread use of interferon-γ-based techniques in our
setting is significantly improving compliance, as it is a
technique that is routinely performed with other ana-
lyses, which avoids the need for the patient to make two
trips to the hospital.
The result of indicator 26-Evaluation of alcoholic in-
take deserves special mention; the low level of compli-
ance with this indicator is because in daily practice,
questions about alcohol intake are asked of patients with
a history of excessive consumption and not of all pa-
tients during regular follow-up as required in the defin-
ition of the indicator.
User satisfaction
The SUCE score was 9.04 points, which is higher than
that obtained with the same questionnaire in other
Spanish hospitals [7, 25]. It is likely that the higher level
of satisfaction is related to the fact that in the hospital
conducting this study, each patient is always treated by
the same physician. In satisfaction studies conducted in
outpatient clinics of different specialties, patients have
suggested that to improve satisfaction, they should be
attended by the same doctor in successive visits [19, 20].
Based on the proposed cut-off value of 6.3 [15],
98.16% of patients were satisfied at the time of the inter-
view. The low proportion of dissatisfied patients makes
comparisons between satisfied and dissatisfied patients
difficult. The Clinical Quality Score was higher than the
Administrative Quality Score, which is a finding previ-
ously described by other authors who have worked with
this questionnaire [7, 26].
Quality indicators and user satisfaction
An association was found between the performance of
check-ups and analyses at least every 6months and pa-
tient satisfaction; this finding should be interpreted with
caution because it is possible that patients who are more
satisfied with health care more regularly keep their
scheduled appointments and that compliance with this
indicator is the result of greater satisfaction and not
cause of it.
It was also found that patients who had been vacci-
nated against hepatitis A virus (HAV) and
Table 4 Univariate analysis of other factors related to
satisfaction (SUCE)
Other factors SUCE
Mean difference (CI 95%)
















Years since HIV diagnosis −0.01 (−0.02;0.01)
CD4+ count (cells/mm3) at the time of submitting the survey
< 200 0
200–500 0.23 (−0.36;0.82)
> 500 0.35 (−0.19;0.90)
Viral load (copies/ml) at the time of delivery of the survey
< 50 0
50–100,000 0.07 (−0.36;0.51)
> 100,000 0.97 (−0.90;2.84)
* p-value < 0.05
Table 5 Multivariable analysis of satisfaction-related factors
(SUCE)
Mean difference (CI 95%)
SUCE
Indicator 16 0.55 (0.08;1.02)
Country of origin (ref. Spain)
Other 0.36 (0.06;0.66)
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pneumococcus were more satisfied, but those who had
received a recommendation for vaccination against
hepatitis B virus (HBV) were not. This disagreement
suggests that although statistically significant differences
were detected, their clinical relevance is probably
minimal.
Compliance with the alcohol intake assessment indica-
tor was associated with less satisfaction because, as it
was applied in this population, it identifies patients with
extreme alcohol consumption habits. Excessive alcohol
consumption is associated with worse patient-reported
satisfaction [27, 28].
In this cohort, compliance with indicator 11-Determin-
ation of plasma VL at the first visit was 100, and 88.14%
of the patients had undetectable VLs when they
responded to the survey, although having an undetect-
able HIV VL did not influence the level of satisfaction.
Some authors have analysed the complex relationship
between quality management strategies and the satisfac-
tion perceived by the patient and did not find any sig-
nificant associations [6]. This fact can be explained by
the low impact that the strategies implemented to in-
crease the quality of care have on patient perceptions
[6]. The direct personal relationship of the patient with
the physician or the nursing staff is a powerful predictor
of the patient’s perception [29, 30]. To comprehensively
assist patients with HIV infection, care indicators should
focus not only on scientific evidence and clinical practice
guidelines but should also promote the best clinical
practice in other areas, such as organizational aspects,
doctor-patient relationships, patient safety and medical
errors [9].
Strengths and limitations
The quality indicators used in this study have been vali-
dated in the Spanish population, and have been shown
to be reliable, with interobserver concordance levels
greater than 95% [13].
Some studies evaluated compliance with quality stan-
dards and related their results to social, demographic,
cultural and clinical factors, but no studies have con-
trasted these results with the level of satisfaction of the
PLVIH as a user of the healthcare system. This perspec-
tive provides a more comprehensive evaluation of the
quality of healthcare offered to patients.
The satisfaction questionnaire used was validated in
the Spanish population and was found to have good psy-
chometric properties. Its use enhances the reliability and
validity of our results, unlike other results obtained with
non-validated questionnaires [19, 20]. The high response
rate also adds value, reducing the possibility of biases
and increasing the representativeness of the sample. As
it is a generic questionnaire for application in outpatient
clinics, it was not possible to analyse aspects specific to
HIV infection, such as the type of antiretroviral therapy
(ART) used, ART dosage, etc.
Offering the questionnaires in English and Spanish
may have led to participation bias because some patients
were not able to read in either of those languages. Deliv-
ering them immediately after the physician’s evaluation
allowed the patient to recall their most recent impres-
sion and improved the quality of the information col-
lected. The timing of the survey avoided the recall bias
that would be expected if the administration of the sur-
vey had been delayed and also prevented the patient’s
perception from being influenced by experiences in
other areas of the hospital. However, the possibility of a
Hawthorne bias, which is the bias that occurs if health-
care staff members modify their habitual attitudes be-
cause they are aware that they will be evaluated, must
not be overlooked; this limitation is inherent in this type
of work. The small number of dissatisfied patients in our
study limited the possibility of comparing satisfied and
dissatisfied patients.
Conclusions
This study demonstrates the need to analyse our clinical
practice with regard to the care of HIV-positive patients
to identify areas of improvement and increase the level
of patient satisfaction with the care received.
HIV VL is used to measure the effectiveness of ART
and is important for the patient’s health but is not re-
lated to their perceptions of their satisfaction with the
health care they have received. The achievement of the
health objectives proposed by scientific societies does
not imply the fulfilment of patient expectations. High-
quality health care requires that health care professionals
satisfy both official requirements and patient needs.
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